Ana Laura Ortega (Ana L Ortega, Ana Laura Ortega Granados)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 10

Top Venues

British journal of cancer

PloS one

Nature communications

JCO clinical cancer informatics

This page only lists publications with an associated author ORCID identifier.

Publications

Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Adrianna Janik, María Torrente, Luca Costabello, Virginia Calvo, Brian Walsh, Carlos Camps, Sameh K Mohamed, Ana Laura Ortega, Vít Nováček, Bartomeu Massutí, Pasquale Minervini, M Rosario Garcia Campelo, Edel Del Barco, Joaquim Bosch-Barrera, Ernestina Menasalvas, Mohan Timilsina, Mariano Provencio Pulla
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer. JCO clinical cancer informatics 7 (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sophie Postel-Vinay, Juan Coves, Matthieu Texier, Mihaela Aldea, Anas Gazzah, Manuel Dómine, David Planchard, Ramon De Las Peñas, Ma Angeles Sala Gonzalez, Santiago Viteri, Javier Perez, Ana Laura Ortega, Teresa Moran, Carlos Camps, Ana Lopez-Martin, Mariano Provencio, Jean-Charles Soria, Benjamin Besse, Bartomeu Massuti, Rafael Rosell
Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial. British journal of cancer 130 (3) (2023)
Sun Min Lim, Solange Peters, Ana Laura Ortega, Gustavo Dix Junqueira Pinto, Christian Sebastián Fuentes, Giuseppe Lo Russo, Michael Schenker, Jin Seok Ahn, Martin Reck, Zsolt Szijgyarto, Neda Huseinovic, Eleftherios Zografos, Elena Buss, Neda Stjepanovic, Sean O'Donnell, Filippo de Marinis
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial. Nature communications 14 (1) (2023)
Fernando Franco, Enric Carcereny, Maria Guirado, Ana Laura Ortega, Rafael López-Castro, Delvys Rodríguez-Abreu, Rosario García-Campelo, Elvira Del Barco, Oscar Juan, Francisco Aparisi, José Luis González-Larriba, Manuel Dómine, Jose M Trigo, Manuel Cobo, Sara Cerezo, Julia Calzas, Bartomeu Massutí, Joaquim Bosch-Barrera, Paola García Coves, Marta Domènech, Mariano Provencio
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry. PloS one 16 (6) (2021)

Ana Laura Ortega.css-eqlu8i{font-size:small;padding-left:4px;} (Ana L Ortega, Ana Laura Ortega Granados)

Publication Activity (10 Years)

Top Topics

Top Venues

Ana Laura Ortega (Ana L Ortega, Ana Laura Ortega Granados)